Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis
Clinical Epidemiology · 2023-06 · Volume 15 · 683-693
DOI: 10.2147/clep.s403314 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Epidemiology, 2023-06. Verfasst von Qianjia Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, China Medical University, Shenyang, People's Republic of China. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Objective
Recent epidemiological evidence shows that there is an association between serum uric acid (SUA) levels and nonalcoholic fatty liver disease (NAFLD). The purpose of this meta-analysis is to summarize all available evidence and assess the associations between SUA levels and NAFLD.
Methods
Using two databases, Web of Science and PubMed, observational studies were applied from the establishment of the databases to June 2022. We used a random effect model to construct the pooled odds ratio (OR) and 95% confidence interval (CI) to appraise the association between SUA levels and NAFLD. The Begg's test was conducted to appraise publication bias.
Results
A total of 50 studies were included, involving 2,079,710 participants (719,013 NAFLD patients). The prevalence and incidence rates (95% CIs) of NAFLD in the patients with hyperuricemia were 65% (57-73%) and 31% (20-41%), respectively. Compared to participants with lower levels of SUA, the pooled OR (95% CI) of NAFLD in those with higher levels of SUA was 1.88 (95% CI: 1.76-2.00). In the subgroup analyses, we found that SUA levels were positively associated with NAFLD in all subgroups, according to study design, study quality, sample size, sex, comparison, age, or country.
Conclusion
This meta-analysis shows that increased SUA levels are positively associated with NAFLD. The results suggested that reducing SUA levels can be a potential strategy for the prevention of NAFLD. Registration Number: PROSPERO-CRD42022358431.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Epidemiology, Shengjing Hospital of China Medical University, China Medical University, Shenyang, People's Republic of China.
- Key Laboratory of Precision Medical Research on Major Chronic Disease, Shenyang, People's Republic of China.
- School of Public Health, Wannan Medical College, Wuhu, People's Republic of China.
- International Educational School, China Medical University, Shenyang, People's Republic of China.
- Department of Infectious Diseases, Shengjing Hospital of China Medical University, China Medical University, Shenyang, People's Republic of China.
- Diagnosis and Treatment Centre for Liver Diseases of Liaoning Province, Shenyang, People's Republic of China.
ORCID-Profile: Laeeqa Manji, Yang Xia
Zitieren
APA
Sun, Q., Zhang, T., Manji, L., Liu, Y., Chang, Q., Zhao, Y., Ding, Y., & Xia, Y. (2023). Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis. Clinical Epidemiology, Volume 15, 683-693. https://doi.org/10.2147/clep.s403314
Vancouver
Sun Q, Zhang T, Manji L, Liu Y, Chang Q, Zhao Y, et al. Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis. Clinical Epidemiology. 2023;Volume 15:683-693. doi:10.2147/clep.s403314
BibTeX
@article{Sun2023,
author = {Sun, Qianjia and Zhang, Tingjing and Manji, Laeeqa and Liu, Yashu and Chang, Qing and Zhao, Yuhong and Ding, Yang and Xia, Yang},
title = {Association Between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Meta-Analysis},
journal = {Clinical Epidemiology},
year = {2023},
volume = {Volume 15},
pages = {683--693},
doi = {10.2147/clep.s403314}
}
EUVIMED